Prothena Corp Public (PRTA) Change in Accured Expenses (2012 - 2026)

Prothena Corp Public (PRTA) recorded quarterly Change in Accured Expenses of -$2.2 million in Q1 2026, up 64.44% quarter-over-quarter from -$6.2 million in Q4 2025, and down 344.18% on a YoY basis from $910000.0 in Q1 2025.

Prothena Corp Public (PRTA) Change in Accured Expenses (2012 - 2026) Analysis & Trends

Prothena Corp Public's Change in Accured Expenses history runs 15 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 344.18% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$18.9 million (down 544.66% YoY), while the FY2025 annual figure was -$15.8 million, up 13.78% from the prior year.
  • Change in Accured Expenses was -$2.2 million for Q1 2026 at Prothena Corp Public, up from -$6.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $8.6 million in Q2 2023 to a low of -$14.5 million in Q1 2024.
  • Historically, Change in Accured Expenses has averaged -$92705.9 across 5 years, with a median of $910000.0 in 2025.
  • The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses soared 11076.92% in 2023, then plunged 936.52% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $39000.0 in 2022, then jumped by 11076.92% to $4.4 million in 2023, then plunged by 54.32% to $2.0 million in 2024, then slumped by 413.86% to -$6.2 million in 2025, then surged by 64.44% to -$2.2 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$2.2 million (Q1 2026), -$6.2 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Prothena Corp Public 479.08 Mn 149.61 Mn - -2.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.22 Mn
Mar 31, 2026 -2.22 Mn
Dec 31, 2025 -6.25 Mn
Dec 31, 2025 -6.25 Mn
Sep 30, 2025 -1.63 Mn
Sep 30, 2025 -1.63 Mn
Jun 30, 2025 -8.81 Mn
Jun 30, 2025 -8.81 Mn
Mar 31, 2025 910,000.00
Mar 31, 2025 910,000.00
Dec 31, 2024 1.99 Mn
Dec 31, 2024 1.99 Mn
Sep 30, 2024 -1.19 Mn
Sep 30, 2024 -1.19 Mn
Jun 30, 2024 -4.65 Mn
Jun 30, 2024 -4.65 Mn
Mar 31, 2024 -14.46 Mn
Mar 31, 2024 -14.46 Mn
Dec 31, 2023 4.36 Mn
Dec 31, 2023 4.36 Mn